Literature DB >> 22467317

Reference intervals and factors contributing to serum cystatin C levels in a Chinese population.

Dong-Dong Li1, Meng-Na Zou, Xin Hu, Mei Zhang, Cheng-Yao Jia, Chuan-Min Tao, Lan-Lan Wang, Bin-Wu Ying.   

Abstract

BACKGROUND: Serum cystatin C (Cys-C), an inhibitor of cysteine proteases, has been suggested as an ideal biomarker of glomerular filtration rate (GFR).
OBJECTIVES: The objective of this study was to describe the reference intervals of serum Cys-C and identify factors associated with serum Cys-C or its variability, including age, gender, creatinine (Crea), blood urea nitrogen (BUN), and uric acid (UA). DESIGN AND METHODS: Serum Cys-C, Crea, BUN, and UA were measured in 4,517 healthy participants aged 8-89 years attending our hospital. Serum Cys-C was analyzed using a latex-enhanced immunoturbidimetric method. Crea were tested by picric acid jaffe method, BUN, and UA by kinetic UV assays.
RESULTS: The predominant characteristic of Cys-C distribution was that Cys-C concentration in age ≥60 years group was the highest (P < 0.05). The differences of Cys-C concentration between males and females existed for subjects aged from 30 to 59 years (P < 0.05). In a multiple model adjusted only for gender and age, gender (β = 0.007) has stronger effect on Cys-C levels, compared with age (β = 0.003). The clinical variables, comprised of age, gender, Crea, BUN, and UA, involved in the fully adjusted equation accounted for 37.6% of variation of Cys-C.
CONCLUSIONS: Ninety-five percent reference intervals for healthy population were partitioned into three categories only by age, 0.59-1.07 mg/L for subjects aged 19-59 years; 0.74-1.14 mg/L for the older aged ≥60 years; and 0.63-1.11 mg/L for children aged ≤18 years. Serum Cys-C is significantly related to gender, age, UA, Crea, and BUN. Besides, there are still other factors contributing to variation of Cys-C levels.
© 2012 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22467317      PMCID: PMC6807548          DOI: 10.1002/jcla.20504

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

1.  Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance.

Authors:  H Finney; D J Newman; C P Price
Journal:  Ann Clin Biochem       Date:  2000-01       Impact factor: 2.057

2.  Reference intervals for the glomerular filtration rate and cell-proliferation markers: serum cystatin C and serum beta 2-microglobulin/cystatin C-ratio.

Authors:  L Norlund; G Fex; J Lanke; H Von Schenck; J E Nilsson; H Leksell; A Grubb
Journal:  Scand J Clin Lab Invest       Date:  1997-10       Impact factor: 1.713

3.  Derivation and validation of cystatin C-based prediction equations for GFR in children.

Authors:  Michael Zappitelli; Paloma Parvex; Lawrence Joseph; Gilles Paradis; Vijaylaxmi Grey; Susie Lau; Lorraine Bell
Journal:  Am J Kidney Dis       Date:  2006-08       Impact factor: 8.860

4.  Reference intervals for serum cystatin C and serum creatinine in adults.

Authors:  E J Erlandsen; E Randers; J H Kristensen
Journal:  Clin Chem Lab Med       Date:  1998-06       Impact factor: 3.694

5.  Determination of serum cystatin C: biological variation and reference values.

Authors:  M M Galteau; M Guyon; R Gueguen; G Siest
Journal:  Clin Chem Lab Med       Date:  2001-09       Impact factor: 3.694

6.  Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement.

Authors:  Eric L Knight; Jacobien C Verhave; Donna Spiegelman; Hans L Hillege; Dick de Zeeuw; Gary C Curhan; Paul E de Jong
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

7.  Metabolic abnormalities are present in adults with elevated serum cystatin C.

Authors:  Paul Muntner; Suma Vupputuri; Josef Coresh; Jaime Uribarri; Caroline S Fox
Journal:  Kidney Int       Date:  2009-03-18       Impact factor: 10.612

8.  Age, gender, and race effects on cystatin C levels in US adolescents.

Authors:  Darcy Groesbeck; Anna Köttgen; Rulan Parekh; Elizabeth Selvin; George J Schwartz; Josef Coresh; Susan Furth
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

9.  Serum cystatin C: a useful marker of kidney function in very old people.

Authors:  Ingela Fehrman-Ekholm; Astrid Seeberger; Jonas Björk; Gunnar Sterner
Journal:  Scand J Clin Lab Invest       Date:  2009       Impact factor: 1.713

10.  Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?

Authors:  E M El-Shafey; G F El-Nagar; M F Selim; H A El-Sorogy; A A Sabry
Journal:  Ren Fail       Date:  2009       Impact factor: 2.606

View more
  4 in total

1.  Are cystatin C-based equations superior to creatinine-based equations for estimating GFR in Chinese elderly population?

Authors:  Xiaohua Pei; Qiao Liu; Juan He; Lihua Bao; Chengjing Yan; Jianqing Wu; Weihong Zhao
Journal:  Int Urol Nephrol       Date:  2012-09-26       Impact factor: 2.370

2.  Correlation between retinal vascular parameters and cystatin C in patients with type 2 diabetes.

Authors:  Qiong Wang; Aili Yang; Fei Sun; Maiye Zhang; Xiayu Xu; Bin Gao
Journal:  Acta Diabetol       Date:  2021-05-21       Impact factor: 4.280

3.  Reference intervals for serum cystatin C and serum creatinine in an adult sub-Saharan African population.

Authors:  Bertille Elodie Edinga-Melenge; Adrienne Tchapmi Yakam; Jobert Richie Nansseu; Catherine Bilong; Suzanne Belinga; Eric Minkala; Prisca Armel Noudjeu; Michel Ondhoua; Samuel Walter Kokola; Vicky Joceline Ama Moor; Gloria Ashuntantang
Journal:  BMC Clin Pathol       Date:  2019-03-18

4.  The prevalence of hyperuricemia and its correlates in Ganzi Tibetan Autonomous Prefecture, Sichuan Province, China.

Authors:  Xin Zhang; Qingtao Meng; Jiayue Feng; Hang Liao; Rufeng Shi; Di Shi; Lachu Renqian; Zeren Langtai; Yuanbin Diao; Xiaoping Chen
Journal:  Lipids Health Dis       Date:  2018-10-12       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.